Zeptosens Company
Zeptosens is a company that provides ultra-sensitive microarray platforms for quantitative proteomic investigations. Their products include ZeptoREADER, ZeptoMARK protein microarray chips, and ZeptoCARRIER for various data points. They also offer proteinarray services, including protein profiling for various samples and assay development. The company's products are used in various applications, including biomarker/target discovery and validation, cell-based screening, mode of action profiling, selectivity profiling, and toxicology investigation. Zeptosens was founded in 2002 and is headquartered in Wilderswil, Switzerland.
Investors
Connections
Total Funding:
CHF14M
Number Of Exists:
Series B
Investor Type:
Company
Employee Number:
1001-5000
Funding Status:
M&A
Technology:
P4 Medicine
Estimated Revenue:
$200 million
Founded Date:
6-20
Industry:
Regenerative Medicine
Investors Number:
2
Investment Stage:
N/A
Headquarters:
Wilderswil, Bern, Switzerland
Last Funding Type:
Series B